BioLight Life (Israel) Probability of Target Price Finishing Over Current Price

    BOLT -- Israel Stock  

    ILS 1,499  24.00  1.63%

    BioLight Life probability of target price tool provides mechanism to make assumptions about upside and downside potential of BioLight Life Sciences Ltd performance during a given time horizon utilizing its historical volatility. Please specify BioLight Life time horizon, a valid symbol (red box) and a target price (blue box) you would like BioLight Life odds to be computed. Check also Trending Equities.
    Horizon     30 Days    Login   to change
    Symbol:
    Refresh Odds

    BioLight Life Target Price Odds to finish over

    Current PriceHorizonTarget PriceOdds to move above current price in 30 days
     1,499 30 days 1,499  ABOUT 7.13%
    Based on normal probability distribution, the odds of BioLight Life to move above current price in 30 days from now is about 7.13% (This BioLight Life Sciences Ltd probability density function shows the probability of BioLight Life Stock to fall within a particular range of prices over 30 days) .
    Assuming 30 trading days horizon, BioLight Life has beta of 0.1371 . This suggests as returns on market go up, BioLight Life average returns are expected to increase less than the benchmark. However during bear market, the loss on holding BioLight Life Sciences Ltd will be expected to be much smaller as well. Additionally BioLight Life Sciences Ltd has an alpha of 0.1371 implying that it can potentially generate 0.1371% excess return over DOW after adjusting for the inherited market risk (beta).
     BioLight Life Price Density 
          Price 
    α
    Alpha over DOW
    =0.14
    β
    Beta against DOW=0.14
    σ
    Overall volatility
    =688.53
    Ir
    Information ratio =0.31

    BioLight Life Alerts

    BioLight Life Alerts and Suggestions

    BioLight Life is not yet fully synchronised with the market data
    BioLight Life generates negative expected return over the last 30 days
    BioLight Life has high likelihood to experience some financial distress in the next 2 years
    The company reported revenue of 4.16M. Net Loss for the year was (13.8M) with profit before overhead, payroll, taxes, and interest of 450K.
    BIO LIGHT ISR LFE has accumulated about 39.18M in cash with (25.3M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.4.

    Price Density Drivers

    BioLight Life Health Indicators

    Float Shares2.58M
    Average Daily Volume Last 10 Day718
    Average Daily Volume In Three Month1.69k
    Check also Trending Equities. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
    Search macroaxis.com